Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Inadequate "caretaker" gene function and human cancer development

Theodore L DeWeese¹, William G Nelson

¹John Hopkins Oncology Center, Baltimore, MD, USA.

Methods in Molecular Biology (Clifton, N.J.)

|April 25, 2003

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Structural and cellular insights into DCTPP1 antagonists and their synergistic action with DNMT inhibitors.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trial.

The Lancet. Oncology·2026

Same author

RRM1 inhibition sensitizes lung adenocarcinoma to decitabine treatment.

Cell death & disease·2026

Same author

A transition zone enriched <i>WIF1</i> ⁺ basal cell subtype is associated with benign prostatic hyperplasia.

bioRxiv : the preprint server for biology·2025

Same author

Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

Same author

Cancer researchers as storytellers for the lay public.

Trends in cancer·2024